-
1Academic Journal
المؤلفون: Swastina Nath Varma, Shany Ye, Sara Ferlin, Charley Comer, Kian Cotton, Maria Victoria Niklison-Chirou
المصدر: Pharmaceutics, Vol 16, Iss 5, p 672 (2024)
مصطلحات موضوعية: medulloblastoma, CEP-18770, cancer, proteasome inhibitors, brain tumors, Pharmacy and materia medica, RS1-441
Relation: https://www.mdpi.com/1999-4923/16/5/672; https://doaj.org/toc/1999-4923; https://doaj.org/article/9011494b255149029f97293b717bfccf
-
2Academic Journal
المؤلفون: Vogl, Dan T, Martin, Thomas G, Vij, Ravi, Hari, Parameswaran, Mikhael, Joseph R, Siegel, David, Wu, Ka Lung, Delforge, Michel, Gasparetto, Cristina
مصطلحات موضوعية: Delanzomib, CEP-18770, proteasome inhibitor, phase I, II study, relapsed, refractory multiple myeloma
Relation: Leukemia & Lymphoma vol:58 issue:8 pages:1872-1879; https://lirias.kuleuven.be/handle/123456789/592736
-
3
المؤلفون: Andrew L. Pecora, Takemi Tanaka, Sreeja Sarojini, Ginah Nightingale, K. Stephen Suh, Rajendra Gharbaran, Andre Goy
المصدر: Critical Reviews in Oncology/Hematology. 87(3):306-322
مصطلحات موضوعية: Ubiquitin proteasome system, Proteasome Endopeptidase Complex, Programmed cell death, Lymphoma, Marizomib, Antineoplastic Agents, Apoptosis, Protein degradation, Bortezomib, CEP-18770, medicine, Animals, Humans, Caspase, Clinical trials-UPS inhibitors, biology, Ubiquitin, Carfilzomib, Hematology, Cell cycle, Cell biology, Proteasome, Oncology, Unfolded Protein Response, biology.protein, Signal transduction, Geriatrics and Gerontology, Proteasome Inhibitors, Signal Transduction, medicine.drug